- The trend backdrop is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
6634
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Sinew Pharma Inc. · Healthcare · Biotechnology
Latest close
57.00 TWD
-6.2%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 16.6% above the Trend Line and sits at 50.0% of its 52-week range. The latest completed week returned -6.2%, after a -11.2% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
27
out of 100
Latest Close
57.00 TWD
14 Aug 2026
1W Return
-6.2%
latest completed week
4W Return
-11.2%
short-term follow-through
12W Return
-9.5%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 35.76% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.2%
Latest completed week; four-week move -11.2%.
Indicator stack
59/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 35.76%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 16.6% above the Trend Line and sits at 50.0% of its 52-week range. The latest completed week returned -6.2%, after a -11.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6912-week average 0.61
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.69Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -11.2% over four weeks, -9.5% over 12 weeks, and 9.2% over one year. The current trend has remained active for 13 consecutive weeks.
Performance by holding period
Active trend streak13 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.27Latest activity-pressure read.
Pressure change-127.0%Four-week change in activity pressure.
Leadership-10.71Latest relative-leadership reading.
RS change-452.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.9%Distance below the 52-week high.
13-week volatility9.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+40.4%Week of 8 May.
Worst week-12.9%Week of 5 Jun.
Latest week-6.2%Week of 14 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks0
Modest losses3
Sharp losses11
Recent vol9.3%13-week weekly-return volatility.
Base vol8.9%52-week weekly-return volatility.
Up/down split19/32Count of positive and negative weeks in the 52-week window.
Average skew8.7% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank96 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank90 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis70/100Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 3/12.
Activity pressure 0.69; No reversal markers Next-Week ExpectancyNegative 35.76%Next-week expectancy is negative with a 35.76% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 57.00 TWD | -6.2% | 48.88 TWD | 55.76 TWD | -0.27 | -10.71 | 340.4K | On |
| 7 Aug 2026 | 60.80 TWD | 12.2% | 48.26 TWD | 55.87 TWD | 0.03 | -2.59 | 334.9K | On |
| 31 Jul 2026 | 54.20 TWD | -10.9% | 47.52 TWD | 55.93 TWD | 0.34 | -11.89 | 561.6K | On |
| 24 Jul 2026 | 60.80 TWD | -5.3% | 47.02 TWD | 56.04 TWD | 0.67 | -3.65 | 421.2K | On |
| 17 Jul 2026 | 64.20 TWD | -8.2% | 46.32 TWD | 56.13 TWD | 1.00 | 3.04 | 651.6K | On |
| 10 Jul 2026 | 69.90 TWD | 3.1% | 45.47 TWD | 56.20 TWD | 1.14 | 4.71 | 605.9K | On |
| 3 Jul 2026 | 67.80 TWD | -7.1% | 44.45 TWD | 56.27 TWD | 1.15 | -2.40 | 927.1K | On |
| 26 Jun 2026 | 73.00 TWD | 13.4% | 43.53 TWD | 56.35 TWD | 1.20 | 9.21 | 2.4M | On |
| 19 Jun 2026 | 64.40 TWD | 16.2% | 42.36 TWD | 56.40 TWD | 1.18 | -8.39 | 751.2K | On |
| 12 Jun 2026 | 55.40 TWD | -4.5% | 41.55 TWD | 56.51 TWD | 1.25 | -18.04 | 853.8K | On |
| 5 Jun 2026 | 58.00 TWD | -12.9% | 41.13 TWD | 56.70 TWD | 1.42 | -17.00 | 906.2K | On |
| 29 May 2026 | 66.60 TWD | 5.7% | 40.66 TWD | 56.87 TWD | 1.53 | -5.23 | 806.2K | On |
| 22 May 2026 | 63.00 TWD | -1.6% | 39.94 TWD | 56.98 TWD | 1.53 | -6.04 | 1.1M | On |
| 15 May 2026 | 64.00 TWD | 17.0% | 39.35 TWD | 57.08 TWD | 1.40 | -3.18 | 4.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.